Literature DB >> 23587123

Association of C1q deposition with renal outcomes in IgA nephropathy.

Hong-Joo Lee1, So Young Choi, Kyung Hwan Jeong, Ji-Youn Sung, Sung Kyoung Moon, Ju-Young Moon, Sang-Ho Lee, Tae-Won Lee, Chun-Gyoo Ihm.   

Abstract

BACKGROUND/AIMS: IgA nephropathy (IgAN) is characterized by a highly variable clinical course. It has been reported that histopathologic lesions are risk factors for the progression of IgAN. The aim of this study was to investigate the relationships between co-deposition of C1q, clinicopathological features, and renal outcomes in patients with IgAN.
METHODS: This retrospective cohort study included 221 patients with primary IgAN who underwent renal biopsy at the Kyung Hee University Medical Center from January 1996 to December 2008. Patients were divided in two groups: C1qpositive and C1q-negative. Using propensity scores to minimize confounding factors, we selected 36 matched C1q-negative patients from among the 203 unmatched C1q-negative patients and compared them with the 18 C1q-positive patients. We evaluated baseline characteristics and the severity of histologic lesions. We expressed the average rate of monthly renal function decline as the slope of eGFR (ΔGFR/M).
RESULTS: 18 patients with IgAN showed mesangial deposition of C1q (8.1%). The C1q-positive patients had higher mean systolic blood pressure values and more impaired renal function than the unmatched C1q-negative patients. However, this association was not seen when the C1qpositive patients were compared with the matched C1q-negative patients. The slope of eGFReGFR/M) declined steeply in the C1q-positive group. The incidence of severe cases of tubulointerstitial inflammation (TII) and fibrosis (TIF) was also greater in the C1q-positive group than the unmatched C1qnegative group, while only the incidence of severe TIF was significantly greater in the C1q-positive group than the matched C1qnegative group. Biopsies from C1q-positive patients showed more intense IgA staining as well as positive rates of IgG and IgM staining than those of unmatched C1q-negative patients. However, compared with the matched C1q-negative group, only the IgG positive rate was significantly higher in the C1q-positive patients. Multiple regression analysis of C1q-positive and matched C1q-negative patients revealed that C1q deposition was a critical determinant of a poorer renal prognosis.
CONCLUSIONS: Mesangial C1q deposition in the glomerulus is associated with a poor renal outcome and severe pathologic features in patients with IgAN. The deposition of C1q in IgAN could therefore serve as an indicator of a poor renal prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587123     DOI: 10.5414/CN107854

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  18 in total

1.  Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children.

Authors:  Song Mao; Xiaoyan Xuan; Yugen Sha; Sanlong Zhao; Chunhua Zhu; Aihua Zhang; Songming Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Current Understanding of the Role of Complement in IgA Nephropathy.

Authors:  Nicolas Maillard; Robert J Wyatt; Bruce A Julian; Krzysztof Kiryluk; Ali Gharavi; Veronique Fremeaux-Bacchi; Jan Novak
Journal:  J Am Soc Nephrol       Date:  2015-02-18       Impact factor: 10.121

3.  Collectin11 and Complement Activation in IgA Nephropathy.

Authors:  Min Wei; Wei-Yi Guo; Bo-Yang Xu; Su-Fang Shi; Li-Jun Liu; Xu-Jie Zhou; Ji-Cheng Lv; Li Zhu; Hong Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2021-10-06       Impact factor: 8.237

4.  Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis.

Authors:  Tibor Tibor Fülöp; Éva Csongrádi; Anna A Lerant; Matthew Lewin; Jack R Lewin
Journal:  J Nephropathol       Date:  2015-04-01

5.  Clinical validation of immunoglobulin A nephropathy diagnosis in Swedish biopsy registers.

Authors:  Simon Jarrick; Sigrid Lundberg; Adina Welander; C Michael Fored; Jonas F Ludvigsson
Journal:  Clin Epidemiol       Date:  2017-01-31       Impact factor: 4.790

6.  Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.

Authors:  Yan Yang; Xi Tang; Yuan Yang; Xinrui Li; Lingzhi Li; Kai Huang; Yi Li; Jing Li; Ping Fu
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 7.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Authors:  Dana V Rizk; Nicolas Maillard; Bruce A Julian; Barbora Knoppova; Todd J Green; Jan Novak; Robert J Wyatt
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

8.  Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.

Authors:  Michael Maes; Aristo Vojdani; Sunee Sirivichayakul; Decio S Barbosa; Buranee Kanchanatawan
Journal:  Mol Neurobiol       Date:  2021-03-06       Impact factor: 5.590

9.  Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.

Authors:  Gabriella Guzzo; Salima Sadallah; Heidi Fodstad; Jean-Pierre Venetz; Samuel Rotman; Daniel Teta; Thierry Gauthier; Giuseppe Pantaleo; Andrea Superti-Furga; Manuel Pascual
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

Review 10.  Hypertension in Chronic Glomerulonephritis.

Authors:  Chun-Gyoo Ihm
Journal:  Electrolyte Blood Press       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.